COMPASS Pathways (5Y6) Price & Analysis

Compare

4 Followers

5Y6 Stock Chart & Stats

€7.05

-€0.46(-9.79%)

At close: Jan 08 4:00 PM EST

€7.05

-€0.46(-9.79%)

Day’s Range― - ―

52-Week Range€2.10 - €7.45

Previous CloseN/A

Volume0.00

Average Volume (3M)326.00

Market Cap

€689.94M

Enterprise Value€622.06M

Total Cash (Recent Filing)€185.94M

Total Debt (Recent Filing)€35.18M

Price to Earnings (P/E)―

Beta0.72

Next Earnings

Feb 26, 2026

EPS Estimate

-0.34

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1.22

Shares Outstanding96,017,044

10 Day Avg. Volume461

30 Day Avg. Volume326

Financial Highlights & Ratios

PEG Ratio1.91

Price to Book (P/B)1.65

Price to Sales (P/S)0.00

P/FCF Ratio-2.14

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€16.66

Price Target Upside136.31% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering11

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Clinical Efficacy And DurabilityCOMP360 produced rapid and sustained reductions in depressive symptoms in pivotal trials, indicating a durable treatment effect that may support strong clinical uptake.

Regulatory Pathway ClarityRegulatory engagement and plans for a rolling new drug application create a clearer approval pathway and reduce binary regulatory risk.

Reimbursement And Delivery InfrastructureNew procedural billing codes combined with leveraging existing interventional psychiatry sites lower reimbursement and operational hurdles, improving commercial feasibility.

Bears Say

Cash Runway And Dilution RiskHigh cash burn and a limited cash runway heighten the need for external financing and potential dilution, posing downside risk to valuation.

Competitive DifferentiationEfficacy seen by some observers as comparable to an existing marketed therapy that requires more clinic visits may limit COMP360's market differentiation and pricing power.

Responder Rate And Retreatment NeedA substantial share of patients showed inadequate response to a single dose, implying many may need retreatment and potentially increasing treatment complexity and costs.

COMPASS Pathways News

Cathie Wood Scoops Up $24M in Figma, Sells DraftKings

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio changes on Thursday, February 19, as shown in daily fund...

1d ago

FIG

ARKG

Psychedelic: Exclusive talk with nonprofit organization MAPS

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Sia Henry, Associate Director of Policy...

2d ago

ATAI

CMND

Compass Pathways 17.5M share Secondary priced at $8.00

The deal priced below last closing price of $8.45. Jefferies, TD Cowen, Cantor Fitzgerald and Stifel are acting...

3d ago

CMPS

Compass Pathways price target raised to $22 from $21 at RBC Capital

RBC Capital raised the firm’s price target on Compass Pathways (CMPS) to $22 from $21 and keeps an...

3d ago

CMPS

Compass Pathways price target raised to $18 from $11 at Morgan Stanley

Morgan Stanley analyst Vikram Purohit raised the firm’s price target on Compass Pathways (CMPS) to $18 from $11...

3d ago

CMPS

Compass Pathways price target raised to $20 from $15 at Canaccord

Canaccord analyst Sumant Kulkarni raised the firm’s price target on Compass Pathways (CMPS) to $20 from $15 and...

3d ago

CMPS

Compass Pathways announces $150M American Depositary Shares offering

Compass Pathways (CMPS) announced the launch of a proposed public offering of $150M of American Depositary Shares, or...

4d ago

CMPS

Midday Fly By: Warner Bros. reopens Paramount talks

The major averages were mixed near noon following the long weekend, reflecting renewed concerns about artificial intelligence-related disruption...

4d ago

DHR

Compass Pathways achieves primary endpoint in Phase 3 COMP006 trial

Compass Pathways (CMPS) announced the successful achievement of the primary endpoint in the ongoing Phase 3 COMP006 trial,...

4d ago

CMPS

Psychedelic: Clearmind reports additional CMND-100 safety results

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on...

9d ago

PBM

AVTX

Compass Pathways initiated with an Outperform at LifeSci Capital

LifeSci Capital analyst Francois Brisebois initiated coverage of Compass Pathways (CMPS) with an Outperform rating and $15 price...

9d ago

CMPS

COMPASS Pathways Announces $150 Million Public Offering

COMPASS Pathways ( ($CMPS) ) just unveiled an announcement. On February 18, 2026, Compass Pathways priced an underwritten...

2d ago

CMPS

Robust Phase 3 Efficacy and Clean Safety Profile Drive Buy Rating on COMPASS Pathways’ CMPS

In a report released today, Ritu Baral from TD Cowen maintained a Buy rating on COMPASS Pathways, with...

4d ago

CMPS

COMPASS Pathways Reports Positive Phase 3 Results in TRD

COMPASS Pathways ( ($CMPS) ) has shared an update. On February 17, 2026, COMPASS Pathways reported that its...

4d ago

CMPS

5Y6 FAQ

What was Compass Pathways Plc’s price range in the past 12 months?

Compass Pathways Plc lowest stock price was €2.10 and its highest was €7.45 in the past 12 months.

What is Compass Pathways Plc’s market cap?

Compass Pathways Plc’s market cap is €689.94M.

When is Compass Pathways Plc’s upcoming earnings report date?

Compass Pathways Plc’s upcoming earnings report date is Feb 26, 2026 which is in 5 days.

How were Compass Pathways Plc’s earnings last quarter?

Compass Pathways Plc released its earnings results on Nov 04, 2025. The company reported -€1.221 earnings per share for the quarter, missing the consensus estimate of -€0.335 by -€0.886.

Is Compass Pathways Plc overvalued?

According to Wall Street analysts Compass Pathways Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Compass Pathways Plc pay dividends?

Compass Pathways Plc does not currently pay dividends.

What is Compass Pathways Plc’s EPS estimate?

Compass Pathways Plc’s EPS estimate is -0.34.

How many shares outstanding does Compass Pathways Plc have?

Compass Pathways Plc has 96,017,044 shares outstanding.

What happened to Compass Pathways Plc’s price movement after its last earnings report?

Compass Pathways Plc reported an EPS of -€1.221 in its last earnings report, missing expectations of -€0.335. Following the earnings report the stock price went down -1.835%.

Which hedge fund is a major shareholder of Compass Pathways Plc?

Currently, no hedge funds are holding shares in DE:5Y6

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

COMPASS Pathways Stock Smart Score

Outperform

Fundamentals

Return on Equity

-205.18%

Trailing 12-Months

Asset Growth

3.34%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Compass Pathways Plc

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

COMPASS Pathways (5Y6) Earnings & Revenues

Historic Earnings Reports

5Y6 Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a generally positive outlook with significant progress in clinical trials, regulatory interactions, and launch preparations. While there was a decrease in cash reserves, the company maintains a strong cash position with a runway into 2027.View all DE:5Y6 earnings summaries

5Y6 Stock 12 Month Forecast

Average Price Target

€16.66

▲(136.31% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","34":"€34","9.25":"€9.25","17.5":"€17.5","25.75":"€25.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":33.9300212,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€33.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.6596404092,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€16.66</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.78600424,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.79</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,9.25,17.5,25.75,34],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.45,7.640770861538462,9.831541723076924,12.022312584615385,14.213083446153846,16.403854307692306,18.59462516923077,20.78539603076923,22.976166892307692,25.166937753846153,27.357708615384613,29.548479476923077,31.739250338461538,{"y":33.9300212,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.45,6.312280031476924,7.174560062953846,8.036840094430769,8.899120125907693,9.761400157384617,10.623680188861538,11.485960220338463,12.348240251815387,13.21052028329231,14.072800314769232,14.935080346246156,15.797360377723077,{"y":16.6596404092,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5.45,5.552769556923077,5.655539113846154,5.758308670769231,5.861078227692308,5.963847784615385,6.066617341538461,6.169386898461538,6.272156455384615,6.374926012307692,6.477695569230769,6.580465126153846,6.683234683076923,{"y":6.78600424,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.88,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.94,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.62,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.12,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.36,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.62,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.779,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.6,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >